Biocause

Biocause is one of the...

• Forbes Global 2000 (#1616).

Biocause is a company listed under the stock ticker 000627 (CN).

View the org chart displaying its 7 main executives

Most searched biographies at Biocause

• Wenxia Zhou, Vice Chairman of the Board, Chief Executive Officer
• Xiaomiao Zhang, Independent Director
• Yiqian Liu, Chairman of the Board

Create your alert
to follow the executive moves at Biocause.

Biocause has 1,860 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma
• Emma Walmsley - Chief Executive Officer and Director at GSK

Learn more about the Pharmaceuticals industry >

Press releases by Biocause

Social media about Biocause

• Biocause on Wikipedia, Google News & Yahoo Finance
• Biocause on LinkedIn, Twitter & YouTube

Call Biocause at +86 27...

View the org chart

Register to receive your alert

Report an error